Information Library

Results for: Connect with investigators, regulators and physicians - Late Phase

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Early phase strategies

    Hear from the Experts — June 15, 2009
    Web cast about Early Phase Strategies.

  • Risk Mitigation Programs

    Brochure — April 16, 2009
    Risk mitigation measures can help keep valuable drugs on the market, even when their safety profile includes adverse events that might negatively affect the benefit risk balance.

  • Risk Assessment & Strategy

    Brochure — April 16, 2009
    Quintiles benefit risk analysis can help you anticipate potential regulatory concerns and highlight the benefit side of your drug’s benefit risk profile.

  • Phase IIIb/IV Studies

    Brochure — April 16, 2009
    New, more efficient delivery models help meet the increasing demands of Phase IIIB/IV Studies.

  • Late Phase and Safety Services

    Brochure — April 10, 2009
    Recent and pending regulatory changes have created an atmosphere of watchful waiting throughout the industry. While it may seem premature to initiate post-marketing studies to collect more “intelligent” safety data, Quintiles Late Phase & Safety Services anticipates that the need for expanded studies will soon spread.

  • Accelerating a Trial Delayed by Slow Approvals

    Case Study — March 27, 2009
    Intense remote monitoring by project coordination center quickly speeds up recruitment

Page 2 of 2 (16 results)

Subscribe to Email Based on Your Interests

Set preferences